Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomarkers in Medicine is Scopus-indexed (Q2, CiteScore 3.2), WoS SCIE. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1752-0363Verify ISSN ↗1752-0371Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry (medical) | 39 / 78 | 50th | Q2 |
| Clinical Biochemistry | 80 / 124 | 35th | Q3 |
| Drug Discovery | 111 / 161 | 31st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q2, CiteScore 3.2.
Biomarkers in Medicine is Q2 in Biochemistry (medical) (rank 39 of 78), Q3 in Clinical Biochemistry (rank 80 of 124) and Q3 in Drug Discovery (rank 111 of 161), by CiteScore 2025.
Biomarkers in Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q2 at the 50th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.582, quartile Q2, with an H-index of 62.
Biomarkers in Medicine is published by Taylor and Francis Ltd. Its print ISSN is 1752-0363 and its online ISSN is 1752-0371.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomarkers in Medicine has an h-index of 73 and a 2-year mean of 2.16 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q2. On 2-year citations it ranks #30 of 77 Scopus journals in Biochemistry (medical).
Biomarkers in Medicine published 143 papers in 2025; its busiest recent year was 2021 with 170. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (44%), Türkiye (14.3%) and India (10.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1.7 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.